(Q35021325)

5 August 2017

1 reference

title

ARCON: a novel biology-based approach in radiotherapy (English)

1 reference

Adaptive radiation therapy

5 August 2017

0 references

2

Johan Bussink

1 reference

5 August 2017

Johannes H A M Kaanders

series ordinal

1

1 reference

PubMed ID

12473514

5 August 2017

Albert J van der Kogel

series ordinal

3

1 reference

5 August 2017

1 December 2002

1 reference

Lancet Oncology Commission

5 August 2017

1 reference

5 August 2017

3

1 reference

5 August 2017

12

1 reference

5 August 2017

728-737

1 reference

The hazard of accelerated tumor clonogen repopulation during radiotherapy

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Carbogen and nicotinamide as radiosensitizers in a murine mammary carcinoma using conventional and accelerated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygenation.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Altered fractionation: limited by mucosal reactions?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

The importance of the pre-irradiation breathing times of oxygen and carbogen (5% CO2: 95% O2) on the in vivo radiation response of a murine sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Dynamics of tumor oxygenation and red blood cell flux in response to inspiratory hyperoxia combined with different levels of inspiratory hypercapnia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Changes in tumor hypoxia measured with a double hypoxic marker technique

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Effects of nicotinamide and carbogen on oxygenation in human tumor xenografts measured with luminescense based fiber-optic probes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Tumour radiosensitization by high-oxygen-content gases: influence of the carbon dioxide content of the inspired gas on PO2, microcirculatory function and radiosensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Effects of breathing a hyperoxic hypercapnic gas mixture on blood oxygenation and vascularity of head-and-neck tumors as measured by magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Improvement in human tumour oxygenation with carbogen of varying carbon dioxide concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Oxygen tension in primary gynaecological tumours: the influence of carbon dioxide concentration

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

The mechanisms by which hyperbaric oxygen and carbogen improve tumour oxygenation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

The response to carbogen breathing in experimental tumour models monitored by gradient-recalled echo magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Blood flow and oxygenation of tumors in mice. I. Effects of breathing gases containing carbon dioxide at atmospheric pressure

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer: feasibility and toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Inspired and expired gas concentrations in man during carbogen breathing

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

ARCON: experience in 215 patients with advanced head-and-neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Tumor radiosensitization by nicotinamide: a result of improved perfusion and oxygenation.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Effect of nicotinamide on the microregional heterogeneity of oxygen delivery within a murine tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Nicotinamide as a repair inhibitor in vivo: studies using single and fractionated X-ray doses in mouse skin and kidneys

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Nicotinamide exerts different acute effects on microcirculatory function and tissue oxygenation in rat tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Effects of the radiosensitising agent nicotinamide on relative tissue perfusion and kidney function in C3H mice

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Possible mechanisms involved in tumor radiosensitization following nicotinamide administration

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Pharmacokinetics of varying doses of nicotinamide and tumour radiosensitisation with carbogen and nicotinamide: clinical considerations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Nicotinamide pharmacokinetics in humans and mice: a comparative assessment and the implications for radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Nicotinamide pharmacokinetics in normal volunteers and patients undergoing palliative radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Administration of nicotinamide during a five- to seven-week course of radiotherapy: pharmacokinetics, tolerance, and compliance

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Administration of nicotinamide during chart: pharmacokinetics, dose escalation, and clinical toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Pharmacology and toxicity of nicotinamide combined with domperidone during fractionated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

The effect of nicotinamide on spontaneous and induced activity in smooth and skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (tirapazamine) and by nicotinamide with carbogen

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Nicotinamide and carbogen: major effect on the radiosensitivity of EMT6 and HRT18 tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Nicotinamide as a radiosensitizer in tumours and normal tissues: the importance of drug dose and timing

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Influence of combined use of nicotinamide and carbogen on rat spinal cord radiation tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Hyperbaric oxygen: the Medical Research Council trials and their clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

What have we learnt from hyperbaric oxygen?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Changes in the oxygenation of head and neck tumors during carbogen breathing

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Carbogen breathing: a system for use in man

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Short communication: the addition of carbogen and nicotinamide to a palliative fractionation schedule for locally advanced breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Accelerated radiotherapy, carbogen and nicotinamide (ARCON) in locally advanced head and neck cancer: a feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Acute effects of accelerated radiotherapy in combination with carbogen breathing and nicotinamide (ARCON)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative group of radiotherapy of the european organization for research and treatment of cancer (EORTC).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

A new method for analyzing the cell kinetics of human brain tumors by double labeling with bromodeoxyuridine in situ and with iododeoxyuridine in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Hypoxia in a human intracerebral glioma model

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Conventional radiotherapy combined with carbogen breathing and nicotinamide for malignant gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Tolerance of nicotinamide and carbogen with radiation therapy for glioblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Carbogen and nicotinamide combined with unconventional radiotherapy in glioblastoma multiforme: a new modality treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: report of European Organization for Research and Treatment of Cancer trial 22933.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

ARCON: accelerated radiotherapy with carbogen and nicotinamide in non small cell lung cancer: a phase I/II study by the EORTC.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen, and nicotinamide

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Dose fractionation and tumour repopulation in radiotherapy for bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Radiotherapy for T2 and T3 carcinoma of the bladder: the influence of overall treatment time.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

Radiotherapy in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900929-4

7 January 2021

10.1016/S1470-2045(02)00929-4

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12473514